Medical specialists from France tagged as investigators in clinical trials studying Papillary Renal Cell Carcinoma
Total 12 results
-
Christine CHEVREAU, MDSeen in:
- Toulouse, Institut Claudius Regaud
- Toulouse, Iuct-Oncopole Institut Claudius Regaud
Trials:- NCT02389244 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Delphine BORCHIELLINI, MDSeen in:
- AM, Nice Cedex 2, Centre Antoine-Lacassagne
- Nice, Centre Antoine Lacassagne
Trials:- NCT05551117 (Principal Investigator)
- NCT04678362 (Principal Investigator)
- NCT05096390 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm;
- Urothelial Carcinoma;
- Papillary Renal Cell Carcinoma Type 2
-
Fabien CALCAGNO, MDSeen in:
- Besançon, CHU Jean Minjoz
- Besançon, CHU de Besançon
Trials:- NCT04268121 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Fréderic ROLLAND, MDSeen in:
- Saint-Herblain, Co-Rene Gauducheau
- Saint-Herblain, Ico-Rene Gauducheau
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Gwenaelle GRAVIS-MESCAM, MDSeen in:
- Marseille, Institut PAOLI-CALMETTES
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Hakim MAHAMMEDI, MDSeen in:
- Clermont-Ferrand, Centre Jean Perrin
Trials:- NCT04678362 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Laurence ALBIGES, MDSeen in:
- Villejuif, Gustave Roussy
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Lionnel GEOFFROIS, MDSeen in:
- Vandœuvre-lès-Nancy, Institut de Cancérologie de Lorraine - Alexis Vautrin
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Marine GROSS-GOUPIL, MDSeen in:
- Bordeaux, CHU Bordeaux
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Remy DELVA, MDSeen in:
- Angers, ICO - Paul Papin
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Stéphane OUDARD, PhDSeen in:
- Paris, AP-HP Hôpital Européen Georges Pompidou
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
Sylvie NEGRIERSeen in:
- Lyon, Centre Leon Bérard
Trials:- NCT05096390 (Principal Investigator)
Conditions:
Clinical Trials on Papillary Renal Cell Carcinoma
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada
-
Australian and New Zealand Urogenital and Prostate...RecruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11.2 Translocation-Related Renal Cell CarcinomaAustralia
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers SquibbActive, not recruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11 Translocation CarcinomaAustralia
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
AstraZenecaSCRI Development Innovations, LLCCompletedPapillary Renal Cell CancerUnited States, Canada, United Kingdom, Spain
-
Jonsson Comprehensive Cancer CenterBeiGene; Driven To CureWithdrawnMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Unresectable Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Clear Cell Papillary Renal Neoplasm | Hereditary Papillary Renal Cell Carcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Clear Cell Renal Carcinoma (Ccrcc) | Papillary Renal Cell Carcinoma (Prcc)United States
-
Mayo ClinicRecruitingClear Cell Renal Cell Carcinoma | Urothelial Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Kidney Oncocytoma | Clear Cell Papillary Renal TumorUnited States